Author： Shakir Saad A.W.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.29, Iss.3, 2006-01, pp. : 187-188
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The FDA Drug Safety Bill: how safe are our drugs?
Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. :
Access to resources
Recommend
Drug reimportation bill dropped by US govt
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 296, 2001-01 ,pp. :
US House passes Medicare drug benefit bill
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. :
Physician education cuts drug costs for RSV infections
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 415, 2003-01 ,pp. :
Drug safety evaluation of defibrotide
Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. :